Figure 9

Percentage of mice in the vehicle, G-CSF, IL-12 pre-only, IL-12 post-only and IL-12 pre-post treatment groups that were tumor-free following the second round of cyclophosphamide treatment. The percentage of mice in the lymphoma study that remained tumor-free at the end of the second round of cyclophosphamide (225 mg/kg), which was 5 weeks from the first round of cyclophosphamide treatment and 7 weeks after tumor inoculation. No mice in the vehicle groups were tumor-free. There was one death in the G-CSF treatment group.